Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is back on traders’ radars on December 16, 2025, after a sharp, high-volume move that has pushed the clinical-stage biotech into “crowded trade” territory—where catalysts, liquidity, and sentiment can matter as much as fundamentals. As
IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Sliding, What the Microsoft AI Deal Really Means, and the Latest Analyst Forecasts (Dec. 16, 2025)

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Sliding, What the Microsoft AI Deal Really Means, and the Latest Analyst Forecasts (Dec. 16, 2025)

IREN Limited stock is having one of those “welcome to modern markets” weeks: a high-voltage mix of AI hype, financing headlines, and crypto-linked volatility—served with a side of investor whiplash. As of 09:45 UTC on Dec. 16, 2025, IREN traded
Go toTop